Problems of ensuring the presence of the Russian Federation among the five leading countries of the world in the field of genomic research[Проблемы Обеспечения Присутствия Российской Федерации В Числе Пяти Ведущих Стран Мира В Области Геномных Исследований]

Genomic research is one of the priorities of the country’s scientific and technological development, which have been supported by the instruction of the President to the Government on the development of a program for the development of advanced genomic research and genetic technologies in the Russian Federation, by the national project “Science”, and by the project of tintegrated scientific -technological program “The Postgenomic technologies: editing to synthetic biology”. The target indicator of NP “Science” is to ensure the presence of the Russian Federation among the five leading countries of the world that carry out research and development in areas determined by the priorities of scientific and technological development, and one of the indicators of the implementation of this indicator is “the place of the Russian Federation by share in the total number of applications for a patent for an invention filed in the world”. Comparison of patent activity of residents of the Russian Federation and the leading countries of the world engaged in research and development using the capabilities of highperformance genome sequencing was performed. A map of the competitive landscape in the technological field under consideration has been built, showing that foreign companies such as DowDuPont, Roche Holding and Illumina have already created impressive by volume patent portfolios. It was noted that in order for the developments, that will be created in the world-class genomic technology centers within the NP Science, to be globally competitive, it is already necessary to create conditions for the active participation of the business sector in government projects and programs.